Literature DB >> 14514726

Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker.

Silja K Sanden1, Jocelyn E Wiggins, Meera Goyal, Lisa K Riggs, Roger C Wiggins.   

Abstract

Podocyte loss and glomerular hypertrophy are associated with development of glomerulosclerosis, suggesting that there may be a maximal area for each podocyte in terms of its capacity to support and maintain the glomerular filter. This study hypothesized that exceeding this maximal threshold will result in mesangial expansion and glomerulosclerosis. It may therefore be useful to measure podocyte number, glomerular volume, and glomerular volume per podocyte in clinical biopsy samples. An approach that uses thick and thin histologic sections cut from paraffin-embedded tissue to measure Wilms' tumor-1 protein-positive podocyte nuclear number and glomerular tuft area was studied. A rat model of aging has been used to track changes in glomerular podocyte number, glomerular volume per podocyte, and glomerular volume. Implications for clinical use of these variables are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514726     DOI: 10.1097/01.asn.0000089829.45296.7c

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  49 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Growth-dependent podocyte failure causes glomerulosclerosis.

Authors:  Akihiro Fukuda; Mahboob A Chowdhury; Madhusudan P Venkatareddy; Su Q Wang; Ryuzoh Nishizono; Tsukasa Suzuki; Larysa T Wickman; Jocelyn E Wiggins; Timothy Muchayi; Diane Fingar; Kerby A Shedden; Ken Inoki; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 10.121

4.  mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.

Authors:  Stéphanie Eid; Suzan Boutary; Kawthar Braych; Ramzi Sabra; Charbel Massaad; Ahmed Hamdy; Awad Rashid; Sarah Moodad; Karen Block; Yves Gorin; Hanna E Abboud; Assaad A Eid
Journal:  Antioxid Redox Signal       Date:  2016-09-12       Impact factor: 8.401

5.  Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

Authors:  Catherine Meyer-Schwesinger; Claudia Lange; Verena Bröcker; Putri Andina Agustian; Putri Andina Agustian; Ulrich Lehmann; Annette Raabe; Martina Brinkmeyer; Eiji Kobayashi; Mario Schiffer; Guntram Büsche; Hans H Kreipe; Friedrich Thaiss; Jan U Becker
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Estimating podocyte number and density using a single histologic section.

Authors:  Madhusudan Venkatareddy; Su Wang; Yan Yang; Sanjeevkumar Patel; Larysa Wickman; Ryuzoh Nishizono; Mahboob Chowdhury; Jeffrey Hodgin; Paul A Wiggins; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

Review 7.  Estimation of glomerular podocyte number: a selection of valid methods.

Authors:  Kevin V Lemley; John F Bertram; Susanne B Nicholas; Kathryn White
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

8.  Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?

Authors:  Guangyu Zhou; Xia Liu; Alfred K Cheung; Yufeng Huang
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

9.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

10.  Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

Authors:  Assaad A Eid; Yves Gorin; Bridget M Fagg; Rita Maalouf; Jeffrey L Barnes; Karen Block; Hanna E Abboud
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.